Augmedix Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Operating Revenue	32.54	23.37
Other Revenue	-	0.25
Revenue	32.54	23.62
Revenue Growth (YoY)	37.76%	-
Cost of Revenue	24.91	15.73
Gross Profit	7.63	7.89
Selling, General & Admin	5.89	3.78
Operating Expenses	6.26	4.01
Operating Income	1.38	3.88
Interest Expense	-0.05	-0.02
Interest & Investment Income	0.24	-
Pretax Income	1.56	3.87
Income Tax Expense	0.65	0.94
Earnings From Continuing Operations	0.91	2.93
Minority Interest in Earnings	-0.02	-0.27
Net Income	0.89	2.66
Net Income to Common	0.89	2.66
Net Income Growth	-66.45%	-
Shares Outstanding (Basic)	63	0
Shares Outstanding (Diluted)	74	0
Shares Change (YoY)	742363.29%	-
EPS (Basic)	0.01	265.55
EPS (Diluted)	0.01	265.55
EPS Growth	-100.00%	-
Free Cash Flow	2.44	3.05
Free Cash Flow Per Share	0.03	305.04
Gross Margin	23.46%	33.42%
Operating Margin	4.23%	16.43%
Profit Margin	2.74%	11.24%
Free Cash Flow Margin	7.50%	12.92%
EBITDA	1.84	4.11
EBITDA Margin	5.65%	17.42%
D&A For EBITDA	0.46	0.23
EBIT	1.38	3.88
EBIT Margin	4.23%	16.43%
Effective Tax Rate	41.65%	24.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.